{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:24:05Z","timestamp":1774520645320,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04700-2","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:15:44Z","timestamp":1771416944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-stratified analysis of invasive lobular carcinoma reveals comparable clinicopathological and molecular features across age groups"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7086-896X","authenticated-orcid":false,"given":"Shiro","family":"Uchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"4700_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4700_CR2","doi-asserted-by":"crossref","unstructured":"Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer. 1998;83:1262\u201373.","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2"},{"key":"4700_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","volume":"208","author":"JL Gnerlich","year":"2009","unstructured":"Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208:341\u20137. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.12.001.","journal-title":"J Am Coll Surg"},{"key":"4700_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJM198608283150906","volume":"315","author":"HO Adami","year":"1986","unstructured":"Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986;315:559\u201363. https:\/\/doi.org\/10.1056\/NEJM198608283150906.","journal-title":"N Engl J Med"},{"key":"4700_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72:524\u201341. https:\/\/doi.org\/10.3322\/caac.21754.","journal-title":"CA Cancer J Clin"},{"key":"4700_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1200\/JCO.1994.12.5.888","volume":"12","author":"AJ Nixon","year":"1994","unstructured":"Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994;12:888\u201394. https:\/\/doi.org\/10.1200\/JCO.1994.12.5.888.","journal-title":"J Clin Oncol"},{"key":"4700_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-194","volume":"6","author":"NS El Saghir","year":"2006","unstructured":"El Saghir NS, Seoud M, Khalil MK, et al. Effects of young age at presentation on survival in breast cancer. BMC Cancer. 2006;6:194. https:\/\/doi.org\/10.1186\/1471-2407-6-194.","journal-title":"BMC Cancer"},{"key":"4700_CR8","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26:3324\u201330. https:\/\/doi.org\/10.1200\/JCO.2007.14.2471.","journal-title":"J Clin Oncol"},{"key":"4700_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jso.21268","volume":"100","author":"A Bharat","year":"2009","unstructured":"Bharat A, Aft RL, Gao F, Margenthaler JA. Patient and tumor characteristics associated with increased mortality in young women (<\u2009or =\u200940 years) with breast cancer. J Surg Oncol. 2009;100:248\u201351. https:\/\/doi.org\/10.1002\/jso.21268.","journal-title":"J Surg Oncol"},{"key":"4700_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93676-w","volume":"11","author":"H Abdel-Razeq","year":"2021","unstructured":"Abdel-Razeq H, Iweir S, Abdel-Razeq R, et al. Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients. Sci Rep. 2021;11:14340. https:\/\/doi.org\/10.1038\/s41598-021-93676-w.","journal-title":"Sci Rep"},{"key":"4700_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0504-3","volume":"13","author":"HA Azim Jr","year":"2015","unstructured":"Azim HA Jr, Nguyen B, Broh\u00e9e S, Zoppoli G, Sotiriou C. Genomic aberrations in young and elderly breast cancer patients. BMC Med. 2015;13:266. https:\/\/doi.org\/10.1186\/s12916-015-0504-3.","journal-title":"BMC Med"},{"key":"4700_CR12","volume-title":"Breast Tumors","author":"World Health Organization Classification of Tumours Editorial Board","year":"2019","unstructured":"World Health Organization Classification of Tumours Editorial Board. Breast Tumors. 5th ed. Lyon, France: International Agency for Research on Cancer; 2019.","edition":"5th ed"},{"key":"4700_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10549-022-06572-w","volume":"193","author":"JA Mouabbi","year":"2022","unstructured":"Mouabbi JA, Hassan A, Lim B, Hortobagyi GN, Tripathy D, Layman RM. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Res Treat. 2022;193:253\u201364. https:\/\/doi.org\/10.1007\/s10549-022-06572-w.","journal-title":"Breast Cancer Res Treat"},{"key":"4700_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173:291\u2013e3046.","journal-title":"Cell"},{"key":"4700_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352. https:\/\/doi.org\/10.1038\/nature10983.","journal-title":"Nature"},{"key":"4700_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479. https:\/\/doi.org\/10.1038\/ncomms11479.","journal-title":"Nat Commun"},{"key":"4700_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","volume":"34","author":"P Razavi","year":"2018","unstructured":"Razavi P, Chang MT, Xu G, et al. The genomic landscape of endocrine-resistant advanced breast cancers. Cancer Cell. 2018;34:427-438.e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.08.008.","journal-title":"Cancer Cell"},{"key":"4700_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-5-44","volume":"5","author":"RR Bastien","year":"2012","unstructured":"Bastien RR, Rodr\u00edguez-Lescure \u00c1, Ebbert MT, et al. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics. 2012;5:44. https:\/\/doi.org\/10.1186\/1755-8794-5-44.","journal-title":"BMC Med Genomics"},{"key":"4700_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/annonc\/mdh062","volume":"15","author":"L Biganzoli","year":"2004","unstructured":"Biganzoli L, Goldhirsch A, Straehle C, et al. Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Ann Oncol. 2004;15:207\u201310. https:\/\/doi.org\/10.1093\/annonc\/mdh062.","journal-title":"Ann Oncol"},{"key":"4700_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.annonc.2019.11.010","volume":"31","author":"R Barroso-Sousa","year":"2020","unstructured":"Barroso-Sousa R, Jain E, Cohen O, et al. Prevalence and mutational determinants of high tumor mutation burden in breast cancer. Ann Oncol. 2020;31:387\u201394. https:\/\/doi.org\/10.1016\/j.annonc.2019.11.010.","journal-title":"Ann Oncol"},{"key":"4700_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, Gatza ML, Beck AH, et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163:506\u201319. https:\/\/doi.org\/10.1016\/j.cell.2015.09.033.","journal-title":"Cell"},{"key":"4700_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01384-6","volume":"23","author":"AE McCart Reed","year":"2021","unstructured":"McCart Reed AE, Kalinowski L, Simpson PT, Lakhani SR. Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Res. 2021;23:6. https:\/\/doi.org\/10.1186\/s13058-020-01384-6.","journal-title":"Breast Cancer Res"},{"key":"4700_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/tbj.13154","volume":"25","author":"Y Ditchi","year":"2019","unstructured":"Ditchi Y, Broudin C, El Dakdouki Y, et al. Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations. Breast J. 2019;25:16\u20139. https:\/\/doi.org\/10.1111\/tbj.13154.","journal-title":"Breast J"},{"key":"4700_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1470-2045(11)70076-6","volume":"12","author":"B Zhang","year":"2011","unstructured":"Zhang B, Beeghly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol. 2011;12:477\u201388. https:\/\/doi.org\/10.1016\/S1470-2045(11)70076-6.","journal-title":"Lancet Oncol"},{"key":"4700_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0519-x","volume":"17","author":"AE McCart Reed","year":"2015","unstructured":"McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and \u2019omics. Breast Cancer Res. 2015;17:12. https:\/\/doi.org\/10.1186\/s13058-015-0519-x.","journal-title":"Breast Cancer Res"},{"key":"4700_CR26","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1002\/cncr.20273","volume":"100","author":"ES Hwang","year":"2004","unstructured":"Hwang ES, Nyante SJ, Chen YY, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004;100:2562\u201372. https:\/\/doi.org\/10.1002\/cncr.20273.","journal-title":"Cancer"},{"key":"4700_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/modpathol.3800621","volume":"19","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Savage K, Lambros MB, et al. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Mod Pathol. 2006;19:999\u20131009. https:\/\/doi.org\/10.1038\/modpathol.3800621.","journal-title":"Mod Pathol"},{"key":"4700_CR28","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00011","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty D, Gao J, Phillips SM, et al. OncoKB: A precision oncology knowledge base. JCO Precis Oncol 2017. https:\/\/doi.org\/10.1200\/PO.17.00011.","journal-title":"JCO Precis Oncol"},{"key":"4700_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transplant"},{"key":"4700_CR30","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.18632\/oncotarget.5844","volume":"7","author":"J Liu","year":"2016","unstructured":"Liu J, Chen K, Mao K, Su F, Liu Q, Jacobs LK. The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: a NCDB analysis. Oncotarget. 2016;7:6063\u201373. https:\/\/doi.org\/10.18632\/oncotarget.5844.","journal-title":"Oncotarget"},{"key":"4700_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10549-018-4950-4","volume":"172","author":"Z Liu","year":"2018","unstructured":"Liu Z, Sahli Z, Wang Y, Wolff AC, Cope LM, Umbricht CB. Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study. Breast Cancer Res Treat. 2018;172:689\u2013702. https:\/\/doi.org\/10.1007\/s10549-018-4950-4.","journal-title":"Breast Cancer Res Treat"},{"key":"4700_CR32","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.ejca.2010.05.013","volume":"6","author":"N Gruel","year":"2010","unstructured":"Gruel N, Lucchesi C, Raynal V, et al. Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. Eur J Cancer. 2010;6:2399\u2013407. https:\/\/doi.org\/10.1016\/j.ejca.2010.05.013.","journal-title":"Eur J Cancer"},{"key":"4700_CR33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jnci\/djx268","volume":"110","author":"C Desmedt","year":"2018","unstructured":"Desmedt C, Salgado R, Fornili M, et al. Immune infiltration in invasive lobular breast cancer. J Natl Cancer Inst. 2018;110:768\u201376. https:\/\/doi.org\/10.1093\/jnci\/djx268.","journal-title":"J Natl Cancer Inst"},{"key":"4700_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jmedgenet-2020-107347","volume":"59","author":"DG Evans","year":"2022","unstructured":"Evans DG, van Veen EM, Byers HJ, et al. High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer. J Med Genet. 2022;59:115\u201321. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107347.","journal-title":"J Med Genet"},{"key":"4700_CR35","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.33698","volume":"149","author":"M Jiang","year":"2021","unstructured":"Jiang M, Qi L, Li L, Wu Y, Song D, Li Y. Caspase-8: a key protein of cross-talk signal way in PANoptosis in cancer. Int J Cancer. 2021;149:1408\u201320. https:\/\/doi.org\/10.1002\/ijc.33698.","journal-title":"Int J Cancer"},{"key":"4700_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-007-9730-5","volume":"110","author":"S Han","year":"2008","unstructured":"Han S, Lee KM, Choi JY, et al. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res Treat. 2008;110:387\u201393. https:\/\/doi.org\/10.1007\/s10549-007-9730-5.","journal-title":"Breast Cancer Res Treat"},{"key":"4700_CR37","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1200\/JCO.21.00640","volume":"39","author":"S Yadav","year":"2021","unstructured":"Yadav S, Hu C, Nathanson KL, et al. Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast. J Clin Oncol. 2021;39:3918\u201326. https:\/\/doi.org\/10.1200\/JCO.21.00640.","journal-title":"J Clin Oncol"},{"key":"4700_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132368","volume":"16","author":"P Apostolou","year":"2024","unstructured":"Apostolou P, Dellatola V, Papathanasiou A, et al. Genetic testing of breast cancer patients with very early-onset breast cancer (30 years) yields a high rate of germline pathogenic variants, mainly in the BRCA1, TP53, and BRCA2 genes. Cancers (Basel). 2024;16:2368. https:\/\/doi.org\/10.3390\/cancers16132368.","journal-title":"Cancers (Basel)"},{"key":"4700_CR39","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1080\/15384101.2015.1041691","volume":"14","author":"A Parish","year":"2015","unstructured":"Parish A, Schwaederle M, Daniels G, et al. Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics. Cell Cycle. 2015;14:2121\u20138. https:\/\/doi.org\/10.1080\/15384101.2015.1041691.","journal-title":"Cell Cycle"},{"key":"4700_CR40","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","volume":"18","author":"AN Brooks","year":"2012","unstructured":"Brooks AN, Kilgour E, Smith PD. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer. Clin Cancer Res. 2012;18:1855\u201362. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0699.","journal-title":"Clin Cancer Res"},{"key":"4700_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrc3090","volume":"11","author":"EA Musgrove","year":"2011","unstructured":"Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer. 2011;11:558\u201372. https:\/\/doi.org\/10.1038\/nrc3090.","journal-title":"Nat Rev Cancer"},{"key":"4700_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00421","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang L, Feizi N, Chi C, Hu P. Association analysis of somatic copy number alteration burden with breast cancer survival. Front Genet. 2018;9:421. https:\/\/doi.org\/10.3389\/fgene.2018.00421.","journal-title":"Front Genet"},{"key":"4700_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00492-0","volume":"8","author":"T Qing","year":"2022","unstructured":"Qing T, Karn T, Rozenblit M, et al. Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ Breast Cancer. 2022;8:119. https:\/\/doi.org\/10.1038\/s41523-022-00492-0.","journal-title":"NPJ Breast Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04700-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04700-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04700-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:10:56Z","timestamp":1774516256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04700-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4700"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04700-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using publicly available, de-identified data obtained from the TCGA, METABRIC, and MSK databases. Ethical approval and informed consent were waived in accordance with the policies of the respective data repositories.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}